Научная электронная библиотека
Монографии, изданные в издательстве Российской Академии Естествознания
Сергеева И. В., Демко И. В.,
СПИСОК ЛИТЕРАТУРЫ
1. Авдеев, С.Н. Пневмония и острый респираторный дистресс-синдром, вызванные вирусом гриппа А/H1N1 [Текст] / С.Н. Авдеев // Пульмонология. – 2010. – Прил. «Грипп А/H1N1: уроки пандемии». – С. 32-46.
2. Авдеев, С.Н. Тяжелые формы пандемического гриппа А/H1N1 2009 [Текст] / С.Н. Авдеев // Атмосфера. Пульмонология и аллергология. – 2010. – № 4. – С. 1-10.
3. Алексеев, А.М. Интенсивная терапия больных с тяжелым течением гриппа А(H1N1), осложненного пневмонией [Текст] / А.М. Алексеев, О.В. Шупинский, К.Н. Храпов // Вестник анестезиологии и реаниматологии. – 2009. – Т.6, № 6. – С. 35-39.
4. Андрейчиков, А.В. Детерминированность метаболического иммунодефицита при аномалиях положения почек: дис. … д-ра мед. наук: 14.00.16 [Текст] / Андрейчиков Александр Владимирович. – Томск, 2003. – 202 с.
5. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике [Текст] / Под ред. А.Г. Чучалина [и др.]. – М.: Атмосфера, 2014. – 45 с.
6. Грипп: эпидемиология, диагностика, лечение, профилактика [Текст] / Под редакцией акад. РАМН проф. О.И. Киселева, д-ра мед. наук Л.М. Цыбаловой, акад. РАМН проф. В.И. Покровского. – М.: ООО «Издательство «Медицинское информационное агентство», 2012. – 496 с.
7. Запольских, А.М. Особенности эпидемиологии и профилактики пандемического гриппа в условиях мегаполиса: дис. … канд. мед наук: 14.02.02 [Текст] / Запольских Анна Михайловна. – Москва, 2014. – 213 с.
8. Зарубаев, В.В. Использование индукторов апоптоза в терапии экспериментальной гриппозной инфекции и предотвращение хронических постгриппозных поражений легких [Текст] / В.В. Зарубаев // Цитология. – 2014. – Т. 56, № 3. – С. 241-247.
9. Использование прогностических математических моделей для выявления больных туберкулезом легких [Текст] / А.Н. Наркевич, К.А. Виноградов, Н.М. Корецкая, А.А. Наркевич // Туберкулез и болезни легких. – 2014. – Т. 91, № 9. – С. 44-45.
10. Методические рекомендации по диагностике и лечению гриппа, утвержденные Министерством здравоохранения РФ. – Москва, М.: Издательство. – 2016. – 29 с.
11. Организация медицинской помощи при внебольничных пневмониях, связанных с эпидемическим подъемом заболеваемости гриппом и ОРВИ: метод. рекомендации для врачей / И.П. Артюхов, И.В. Демко, Е.Е. Корчагин [и др.]; под.ред. А.Г. Чучалина. М-во здравоохранения Краснояр. края, ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России. – М., 2016. – 108 с.
12. Особенности современного гриппа [Текст] / Н.А. Малышев, М.В. Базарова, Г.Н. Кареткина [и др.] // Туберкулез и социально-значимые забоевания. – 2014. – № 4. – С. 43-51.
13. Показатели воспалительных реакций, гемостаза и эндотелиоза при тяжелой пневмонии в зависимости от исходов заболевания и их сопряжение [Текст] / А.П. Момот, И.В. Балацкая, Т.И. Мартыненко и др. // Современные проблемы науки и образования. – 2014. – № 2. – С. 344.
14. Пульмонология: национальное руководство [Текст] / под ред. А.Г. Чучалина. – М.: ГЭОТАР–Медиа, 2014. – 800 с.
15. Романова, Е.Н. Пневмонии у больных гриппом А/H1N1/09: клинико-патогенетические закономерности и исходы: дис. … д-ра мед. наук: 14.00.05 [Текст] / Романова Елена Николаевна. – Чита, 2014. – 314 с.
16. Савченко, А.А. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови человека биолюминесцентным методом [Текст] / А.А. Савченко, Л.Н. Сунцова // Лаб. дело. – 1989. – № 11. – С. 23-25.
17. Савченко, А.А. Метаболические особенности лимфоцитов крови у людей с нарушениями иммунореактивности, проживающих в разных климато-географических условиях: Автореф. дис. … д-ра мед. наук [Текст] / А.А. Савченко. – Томск, 1996. – 30 с.
18. Савченко, А.А. Основы клинической иммунометаболомики [Текст] / А.А. Савченко, А.Г. Борисов. – Новосибирск: Наука, 2012. – 263 с.
19. Савченко, А.А. Содержание АТФ и активность НАД(Ф)-зависимых дегидрогеназ в лимфоцитах при иммунодефицитассоциированных заболеваниях у пришлых жителей Эвенкии [Текст] / А.А. Савченко, С.В. Смирнова, А.Г. Борисов // Бюлл. СО РАМН. – 2010. – Т. 30, № 3. – С. 33-38.
20. Симаненков, В.И. Внебольничная пневмония [Текст] / В.И. Симаненков, Е.А. Лутаенко // Лечащий врач. – 2014. – № 11. – С. 112–114.
21. Федеральные клинические рекомендации Российского респираторного общества по диагностике и лечению тяжелых форм гриппа [Текст] / А.Г. Чучалин, С.Н. Авдеев, А.Л. Черняев [и др.] // Пульмонология. – 2014. – № 5. – С. 11–19.
22. Фесенко, О.В. Тяжелая внебольничная пневмония и шкалы оценки прогноза [Текст] / О.В. Фесенко, А.И. Синопальников // Практическая пульмонология. – 2014. – № 2. – С. 56-59.
23. Харитонов, М.А. Пневмонии [Текст] / М.А. Харитонов, В.А. Андреев, Т.И. Оболенская // Медицинская лабораторная диагностика: программы и алгоритмы. – М.: ГОЭТАР-Медиа, 2014. – Гл. 15. – С. 430–458.
24. Чаванина, С.А. Клинико-патогенетические закономерности течения внебольничных пневмоний в период эпидемии гриппа А А/H1N1/09 у детей: дис. … канд. мед. наук: 14.01.08 [Текст] / Чаванина Светлана Александровна. – Хабаровск, 2014. – 142 с.
25. Чучалин, А.Г. Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых [Электронный ресурс] / А.Г. Чучалин // Российское респираторное общество. – 2014. – Режим доступа: http://www.pulmonology.ru/publications/guide.php.
26. Чучалин А.Г. Пневмония: актуальная проблема медицины ХХI века [Текст] / А.Г. Чучалин // Пульмонология. – 2015. – Т. 25, № 2. – С. 133-142.
27. Чучалин, А.Г. Пневмония: актуальная проблема медицины XXI века [Текст] / А.Г. Чучалин // Терапевтич. архив. – 2016. – Т. 88, № 3. – С. 4-12.
28. Эпидемический сезон 2013–2014 гг. Госпитальный мониторинг и противовирусная терапия гриппа [Текст] / Л.В. Колобухина, Е.И. Бурцева, М.Ю. Щелканов [и др.] // Терапевтический архив. – 2014. – Т. 86, № 10. – С. 52-59.
29. A case of severe ARDS caused by novel swine-origin influenza (A/H1N1pdm) virus: a successful treatment with direct hemoperfusion with polymyxin B-immobilized fiber [Text] / T. Yokoyama [et al.] // J. Clin. Apher. – 2010. – Vol. 25 (6). – Р. 350-353.
30. A Complicated Message: Identification of a Novel PB1-Related Protein Translated from Influenza A Virus Segment 2 mRNA [Text] / H.M. Wise, A. Foeglein, J. Sun [et al.] // J. Virol. – 2009. – Vol. 83, № 16. – P. 8021-8031.
31. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A(H1N1) [Text] / J.K. Louie, M. Acosta, M.C. Samuel [et al.] // Clin. Infect. Dis. – 2011. – Vol. 52, N 3. – P. 301–312.
32. Adeola, O.A. Detection of pandemic strain of influenza virus
(A/H1N1/pdm09) in pigs, West Africa: implications and considerations for prevention of future influenza pandemics at the source [Электронный ресурс] / O.A. Adeola, B.O. Olugasa, B.O. Emikpe // Infect Ecol Epidemiol. – 2015. – 5: 30227. – Режим доступа: http://dx.doi.org/10.3402/iee.v5.30227.
33. Agarwal, P.P. Chest radiographic and CT finings in novel swine-origin influenza A (HlNl) virus [Text] / P.P. Agarwal, S. Sinti, E.A. Kazerooni // Am. J. Roentgenol. – 2009. – P. 1488-1493.
34. Allen, S.J. Chemokine: receptorstructure, interactions, andantagonism [Text] / S.J. Allen, S.E. Crown, T.M. Handel // Annu Rev Immunol. – 2007. – Vol. 25. – Р. 787-820.
35. Almansa, R. Immunopathogenesis of 2009 pandemic influenza [Text] / R. Almansa, J.F. Bermejo-Martin, R.O. De Lejarazu Leonardo // Enferm. Infecc. Microbiol. Clin. – 2012. – Vol. 30, Suppl. 4. – P. 18-24.
36. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1)2009 influenza virus / Y. Liu et al. // Journal of Virology. 2010. – V.84, № 22. – P. 12069-12074.
37. An under-recognized influenza epidemic identified by rapid infiuenza testing, Southern Spi Lanka, 2013 [Text] / L.G. Tillekeratne, T. Qstybe, C.K. [et al.] // Bodinayake American Journal of Tropical Medicine and Hygiene. – 2015. – Т. 92, № 5. – P. 1023-1029.
38. Bedford, T. Global circulation patterns of seasonal influenza viruses vary with antigenic drift [Text] / T. Bedford, S. Riley, I.G. Barr // Nature. – 2015. – 523 (7559). – P. 217-220.
39. Benes, J. Scoring systems to evaluate prognosis of community-acquired pneumonias [Text] / J. Benes, O. Dzupova, Z. Blechova [et al.] // Vnitr. Lek. – 2012. – Vol. 58, № 5. – P. 357-364.
40. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia [Text] / P. Schuetz, A. Litke, W.C. Albrich [et al.] // Curr. Opin. Infect. Dis. – 2013. –
Vol. 26, № 2. – P. 159-167.
41. Boyum, A. Separation of leukocytes from blood and bone marrow [Text] / A. Boyum // Scand. J. Clin. Lab. Invest. – 1968. – Vol. 21, № 1. – P. 90-109.
42. Brockwell-Staats C. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A(H1N1) [Text] / C. Brockwell-Staats, R.G. Webster, R.J. Webby // Influenza Respir. Vir. – 2009. – Vol. 3. – P. 207-213.
43. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses [Text] / K. Scheible [et al.] // Vaccine. – 2011. – Vol. 29 (11). – P. 2159-2168.
44. CDC, 2009. Novel Influenza A (H1N1) Virus Infections in Three Pregnant Women – United States, April-May 2009. Centers for Disease Control and Prevention (US) [Text] // MMWR. Morbidity and mortality weekly report. 2009: 58 (18). P. 497–500. Situation Update,
8 January 2014.
45. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study [Text] / D.M. Musher, I.L. Roig, G. Cazares [et al.] // J. Infect. – 2013. –
Vol. 67. – P. 11-18.
46. Cellular immune correlates of protection against symptomatic pandemic influenza [Text] / S. Sridhar [et al.] // Nature Medicine. – 2013. – Vol. 19. – P. 1305-1312.
47. Chakrabarti, A.K. An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses [Text] / A.K. Chakrabarti, G. Pasricha // J. Virol. – 2013. –
Vol. 440 (2). – P. 97-104.
48. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin [Text] / B. García-Barreno [et al.] // J. Gen. Virol. – 2014. –Vol. 95. – P. 1033-1042.
49. Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus [Text] / M.L. Hillaire [et al.] // J. Virol. – 2011. – Vol. 85 (22). – P. 12057-12061.
50. Chen, J. The immunobiology of SARS [Text] / J. Chen, K. Subbarao // Annu RevImmunol. – 2007. – Vol.25. – Р. 443-472.
51. Сhoby, B.A. Respiratory infections: community-acquired pneumonia [Text] / B.A. Choby, P. Hunter // F.P. Essent. – 2015. –
Vol. 429. – P. 11-21.
52. Clinical and Epidemiologic Characteristics of Hospitalized Patients with 2009 H1N1 Influenza Infection [Text] / S. Nayman Alpat, G. Usluer, I. Ozgunes [et al.] // Influenza Res Treat. – 2012. –
Vol. 23. – P. 1-5.
53. Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection [Text] / H. Tse [et al.] // PLoS ONE. – 2011. – Vol. 6 – P. e22534.
54. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection [Text] / N. Hagau [et al.] // Crit. Care Med. – 2010. – Vol. 14 (6). – P. 203.
55. Clinical aspects of pandemic 2009 influenza A/H1N1/ virus infection [Text] / E. Bautista [et al.] // N. Engl. J. Med. – 2010. –
Vol. 362. – Р. 1708-1719.
56. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009 [Text] / N. Komiya, Y. Gu, H. Kamiya [et al.] // Euro Surveill. – 2009. – Vol. 14, № 29. – P. 19272.
57. Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome [Text] / J.L. Clarke, T.I. Vulliamy, D. Roper [et al.] // Blood Cells Mol. Dis. – 2003. – Vol. 30, № 3. – P. 258-263.
58. Community-acquired pneumonia due to pandemic A (H1N1)2009 influenza virus methicillin resistant staphylococcus aureus co-infection [Text] / R.J. Murray [et al.] // PLoS ONE. – 2010. – Vol. 5(1). – P. 8705.
59. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study [Text] / D. Viasus, C. Marinescu, A. Villoslada [et al.] // J. Infect. – 2013. – Vol. 67, № 3. – P. 185-193.
60. Complex formation between malate dehydrogenase and isocitrate dehydrogenase from Bacillus subtilis is regulated by tricarboxylic acid cycle metabolites [Text] / M. Bartholomae, F.M. Meyer, F.M. Commichau [et al.] // FEBS J. – 2014. – № 281(4). – Р. 1132–1143.
61. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon [Text] / L. Cervantes-Barragan, R. Zust, F. Weber [et al.] // Blood. – 2007. – Vol. 109, № 3. – Р. 1131-1137.
62. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses [Text] / S. Gras [et al.] // PNAS. – 2010. – Vol. 107 (28). – P. 12599-12604.
63. Cunha, B.A. Swine influenza (H1N1) pneumonia: clinical considerations [Text] / B.A. Cunha // Infect Dis. Clin. N. Am. – 2010. – № 24. – P. 203-228.
64. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis [Text] / Gao R. [et al.] // Am. J. Pathol. – 2013. –
Vol. 183. – P. 1258-1268.
65. DeBerardinis, R.J. Cellular metabolism and disease: what do metabolic outliers teach us? [Text] / R.J. DeBerardinis, C.B. Thompson // Cell. – 2012. – Vol. 148, № 6. – P. 1132-1144.
66. De Soli, P. Whole blood chemiluminescence: a new technical approach to assess oxygen-dependent microbial activity of granulocytes [Text] / P. De Soli, S. Lippa, G. Lixxarru // J. Clin. Lab. Autom. – 1983. – Vol. 3. – P. 391-400.
67. Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection [Text] / Xichao Guo, Yu Chen, Xuefen Li, Haishen Kong [et al.] // J. Virol. – 2011. – Vol. 8. – P. 1-6.
68. ECDC. Influenza in Europe. Season 2015-2016. [Электронный ресурс]. Режим доступа: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/PublishingImages/influenza-end-of-season-2015-16.jpg.
69. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults [Text] / D.I. Bernstein, K.M. Edwards, C.L. Dekker [et al.] // J. Infect Dis. – 2008. – Vol. 197, № 5. –
P. 667-675.
70. Emergence of a novel swine-origin influenza A (H1N1) virus in humans [Text] / Novel swine-origin influenza A (H1N1) virus investigation team; F.S. Dawood, S. Jain, L. Finelli [et al.] // N Engl J Med. – 2009. –Vol. 360, № 25. – P. 2605-2615.
71. Enhanced epidemiological surveillance of influenza A (H1N1)v in Italy [Text] / C. Rizzo, S. Declich, A. Bella [et al.] // Euro Surveill. – 2009. – Vol.14, № 27. – P. 19266.
72. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection [Text] / J.R. Teijaro [et al.] // Cell. – 2011. – Vol. 146. – P. 980-991.
73. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis byrespiratory syncytial virus [Text] / A.E. Alvarez, F.A. Marson, C.S. Bertuzzo [et al.] // J. Pediatr. (Rio J). – 2013. – Vol. 89(6). – P. 531-543.
74. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza [Text] / M.L. Metersky, R.G. Masterson, H. Lode [et al.] // Int. J. Infect. Dis. – 2012. – Vol. 16. – P. 321–331.
75. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009 [Text] / L. Vaillant [et al.] // Eurosurveillance. – 2009. – Vol. 14 (33). – P. 1-6.
76. Epidemiology of influenza A (H1N1)v virus infection in Japan, May – June 2009 [Text] / T. Shimada, Y. Gu, H. Kamiya [et al.] // Euro Surveill. – 2009. – Vol. 14, № 24. – P. 19244.
77. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008–2009 and 2013–2014 in Germany [Text] / M. Wedde, B. Biere, T. Wolff [et al.] // Int J Med Microbiol. – 2015. – T. 305, № 7. – C. 762-75.
78. European Centre for Disease Prevention and Control and the World Health organization Regional Office for Europe [Electronic resource]. – Mode of access: http://www.pitt.edu/ – super1/lecture/lec34601/036/htm. (15.04.2012).
79. European Centre for Disease Prevention and Control, Surveillance Report, January 8,2010,/ (Электронный ресурс) – Режим доступа: URL: http://ecdc.europa.eu/en/activities/ surveillance/EISNNewsletter/100108_EISN.
80. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California [Text] / J. Louie [et al.] // JAMA. – 2009. – Vol. 302. – P. 1896-1902.
81. Factors associated with early hospital discharge of adult influenza patients [Text] / N. Lee, P.K. Chan, K.W. Choi [et al.] // Antivir Ther. – 2007. – Vol. 12, № 4. – P. 501-508.
82. Fraser, Pandemic potential of a strain of influenza A(H1N1): early findings [Text] / Fraser C., Donnelly C.A., Cauchemez S. et al. // Science. – 2009. – Vol. 324. – P. 1557-1561.
83. Francis, T.J. A serological recapitulation of human infection with different strains of influenza virus [Text] / Francis T.J., Davenport F.M., Hennessy A.V. // Trans. Assoc. Am. Phys. 1953, 66: 231-239.
84. Frequency of D222G haemagglutinin mutant of pandemic (H1N1) pdm09 influenza virus in Tunisia between 2009 and 2011 [Text] / A.E. Moussi [et al.] // Diagnostic Pathology. – 2013. –
Vol. 8 (124). – P. 1-5.
85. Frieman, M. SARS coronavirus and innate immunity [Text] / M. Frieman, M. Heise, R. Baric // Virus Res. – 2008. – Vol. 133, № 1. – Р. 101-112.
86. Fujihashi, K. Mucosal immunosenescence: new developments and vaccines to control infectious diseases [Text] / K. Fujihashi, H. Kiyono // Trends in immnology. – 2009. – Vol. 30, № 7. – P. 334-343.
87. Functional polymorphisms of interferon-gamma affect pneumonia-induced sepsis [Text] / D. Wang [et al.] // PLoS One. – 2014. –
Vol. 9. – P. e87049.
88. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages [Text] / J. Zhou, H.K. Law, C.Y. Cheung [et al.] // J Infect Dis. – 2006. –
Vol. 193, № 7. – P. 945-953.
89. Galvаn, J.M. Review of Non–Bacterial Infections in Respiratory Medicine: Viral Pneumonia [Text] / J.M. Galván, O. Rajas, J. Aspa // Arch Bronconeumol. – 2015. – Vol. 51, № 11. – P. 590–597.
90. Garcia-Souza, L.F. Mitochondria: biological roles in platelet physiology and pathology [Text] // L.F. Garcia-Souza, M.F. Oliveira // Int J Biochem Cell Biol. – 2014. – № 50. – Р. 156–160.
91. Gilca, R. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada [Text] / R. Gilca, G. De Serres // Influenza Other Respi Viruses. – 2011. – Vol. 5(4). – P. 247-255.
92. Glucan microarray analysis of the hemagglutinins from modem and pandemic influenza viruses reveals different receptor specificities [Text] / J. Stevens [et al.] // J. Mol. Biol. – 2006. – Vol. 335. –
P. 1143-1155.
93. Glucose-6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells [Text] / S. Pan, C.J. World, C.J. Kovacs [et al.] // Arterioscler. Thromb. Vasco BioI. – 2009. – Vol. 29, № 6. – P. 895-901.
94. Glutathione depletion reveals impairment of antigen processing and-inhibition of cathepsin activity by nitric oxide in antigen-presenting cells [Text] / G. Lemaire, O. Guittet, M.F. Vesin [et al.] // Mol. Immunol. – 2009. – Vol. 46, № 6. – P. 1100-1108.
95. Glutathione dysregulation and the etiology and progression of human diseases [Text] / N. Ballatori, S.M. Krance, S. Notenboom [et al.] // Biol. Chem. – 2009. – Vol. 390, № 3. – P. 191-214.
96. Gutierrez-Pizarraya, A. Unexpected severity of cases of influenza B infection in patients that require hospitalization duringn the first postpandemic wave [Text] / A. Gutierrez-Pizarraya, P. Pirez-Romero, R. Alvarez [et al.] // J. Inf. – 2012. – Vol. 65(5). – P. 423-430.
97. Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8+ T-Cell Differentiation [Text] / Pratip K. Chattopadhyay, Kiprotich Chelimo, Paula B. Embury [et al.] // J. Virol. – 2013. – Vol. 87, № 3. – P. 1779-1788.
98. Hospitalized patients with novel influenza A (H1N1) virus infection–California, April–May, 2009 [Text] / Centers for Disease Control and Prevention // MMWR. – 2009. – Vol. 58, № 19. – Р. 536-541.
99. Human Cytomegalovirus Induces the Activity and Expression of Acetyl-Coenzyme A Carboxylase, a Fatty Acid Biosynthetic Enzyme Whose Inhibition Attenuates Viral Replication [Text] / Cody M. Spencer, Xenia L. Schafer, Nathaniel J. Moorman [et al.] // J. Virol. – 2011. – Vol. 85, № 12. – P. 5814-5824.
100. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009 [Text] / World Health Organization // Wkly Epidemiol Rec. – 2009. – Vol. 84, № 21. – P. 185-189.
101. Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009 [Text] / World Health Organization // Wkly Epidemiol Rec. – 2009. – Vol.84, № 24. – P. 237-244.
102. Human influenza viruses and CD8+ T Cell responses [Text] / E.J. Grant, S.M. Quinõnes-Parra, E.B. Clemens, K. Kedzierska // Current Opinion in Virology. – 2016. – Vol. 16. – P. 132-142.
103. Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension [Text] / S. Chettimada, R. Gupte, D. Rawat [et al.] // Am J Physiol Lung Cell Mol Physiol. – 2015. – № 308(3). – Р. 287–300.
104. Jose, R.J. Community-acquired pneumonia [Text] / R.J. Jose, J.N. Periselneris, J.S. Brown // Curr. Opin. Pulm. Med. – 2015. – Vol. 21, № 3 – Р. 212-218.
105. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury [Text] / Y. Imai, K. Kuba, G.G. Neely [et al.] // Cell. – 2008. – Vol. 133, № 2. – P. 235-249.
106. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand [Text] / P. Oster, J.O’ Hallahan, I. Aaberge [et al.] // Vaccine. – 2007. – Vol. 25, № 16. – P. 3075-3079.
107. Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates [Text] / J. Li [et al.] // Cell. Mol. Immunol. – 2013. – Vol. 10 (5). – P. 437-443.
108. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia [Text] / K. Sochorova, R. Horvath, D. Rozkova [et al.] // Blood. – 2007. – Vol. 109, № 6. – P. 2553-2556.
109. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase [Text] / G. Cappai, M. Songini, A. Doria [et al.] // Diabetologia. – 2011. – Vol. 54, № 6. – P. 1539-1542.
110. Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein [Text] / B.G. Hale, J. Steel, R.A. Medina [et al.] // J. Virol. – 2010. – Vol. 84, № 14. – P. 6909-6922.
111. Infection and Autoimmunity [Text] / Nancy Agmon Levin, Noel R. Rose, Y. Shoenfeld. – Gardners Books, 2004. – 768 р.
112. Influenza A (H1N1)pdm09 virus suppresses RIG1 initiated innate antiviral responses in the human lung [Text] / W. Wu, W. Zhang, J.L. Booth, J.P. Metcalf J.P. [et al.] // PLOS ONE. – 2012. – V. 7,
№ 11. – e49856.
113. Influenza A(H1N1)pdm09: beyond the pandemic [Text] / D. Viasus, A. Antоn, T. Pumarola, J. Carratalà // Enferm. Infecc. Microbiol. Clin. – 2012. – Vol. 30, № 4. – P. 54-57.
114. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation [Text] / M.A. Hoeve, A.A. Nash, D. Jackson [et al.] // Plos One. – 2012. – V. 7. – № 1. – e29443.
115. Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 [Text] / D. Zamarin, A. Garcia-Sastre, X. Xiao [et al.] // PLoS Pathog. – 2005. – Vol. 1., № 1. – P. 0040-0054.
116. Influenza virus receptors in the human airway [Text] / K. Shinya, M. Ebina, S. Yamada [et al.] // Nature. – 2006. – Vol. 440. – P. 435-436.
117. Influenza infection and risk of acute pulmonary embolism [Text] / M. Van Wissen, T.T. Keller, B. Ronkes [et al.] // Thromb J. – 2007. – Oct 16, Vol. 5. – Р. 16.
118. Intensive-care patients with severe novel influenza A (H1N1) virus infection – Michigan, June 2009 [Text] / Centers for Disease Control and Prevention // MMWR. – 2009. – Vol. 58, № 27. – Р. 749-752.
119. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells [Text] / M. Spiegel, K. Schneider, F. Weber [et al.] // J Gen Virol. – 2006. – Vol. 87, № 7. – P. 1953-1960.
120. In vitro and in vivo characterization of new swine-origin H1N1 influenza virus [Text] / Y. Itoh, K. Shinya, M. Kiso [et al.] // Nature. – 2009. – Vol. 460, № 7258. – P. 1021-1025.
121. Kash, J.C. The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis [Text] / J.C. Kash, J.K. Taubenberger // Am. J. Pathol. – 2015. – Vol. 185, № 6. – P. 1528-1536.
122. Kauffman, K.J. Advances in flux balance analysis [Text] / K.J. Kauffman, P. Prakash, J.S. Edwards // Current Opinion in Biotechnology. – 2003. – Vol. 14, № 5. – P. 491–496.
123. Killip, M.J. Influenza virus activation of the interferon system [Text] / M.J. Killip, R.E. Randall, E. Fodor // Virus Research. – 2015. – Vol. 209. – P. 11-22.
124. Kotzamanis, K. Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection [Text] / K. Kotzamanis, A. Angulo, P. Ghazal1 // Med. Microbiol. Immunol. – 2015. – Vol. 204, № 3. – P. 395-407.
125. Kuiken T. Pathology of human influenza revisited / T. Kuiken, J. Taubenberger // Vaccine. – 2008. – Vol. 26. – P. 59–66.
126. Lacoma, A. Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores [Text] / A. Lacoma, A. Bas, P. Tudela [et al.] // Enferm. Infecc. Microbiol. Clin. – 2014. – Vol. 32, № 3. – P. 140-146.
127. Lai, C. Cytokines Network and Influenza Virus Infection [Text] / C. Lai, X. Wang, P. Yang // Clin. Microbial. – 2014. – Vol. 3 (147). – doi:10.4172/2327-5073.1000147.
128. Levinson, W. Review of Medical Microbiology and Immunology [Text] / W. Levinson. – McGraw-Hill, 2010. – 640 p.
129. Liderot, K. Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1 [Text] / K. Liderot, M. Ahl, V. Ozenci // Biomed Res Int. – 2013. – Vol. 6. – P. 1-6.
130. Littleton, S.W. Impact of obesity on respiratory function [Text] / S.W. Littleton // Respirology. – 2012. – Vol. 17, № 1. – P. 43-49.
131. Longo, D.L. Community-acquired pneumonia [Text] / D.L. Longo // N. Engl. J. Med. – 2014. – Vol. 371. – P. 1619-1628.
132. Manchini, G. Immunochemical quantitation of antigens by single radial diffusion [Text] / G. Manchini, A.O. Carbonaro, J.F. Haremans // Immunochemistry. – 1965. – Vol. 2, № 3. – P. 235-255.
133. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites [Text] / S. Mauerer-Stroh, J. Ma, R. Tze Chuen Lee [et al.] // Biology Direct. – 2009. – Vol. 4, № 5. – P. 1-9.
134. Marti, C. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis [Text] / C. Marti, N. Garin, O. Grosgurin [et al.] // Crit. Care. – 2012. – Vol. 27,
№ 16. – P. 141.
135. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes [Text] / Gannage M., Dormann D., R. Albrecht [et al.] // Cell. Host. Microbe. – 2009. – Vol. 6. – P. 367-380.
136. Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase C-mediated Activation of ERK Signaling [Text] / H. Marjuki, M.I. Alam, C. Ehrhardt [et al.] // J. Biol. Chem. – 2006. – Vol. 281, № 24. –
P. 16707–16715.
137. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms [Text] / K.K. McKinstry [et al.] // J. Clin. Invest. – 2012. – Vol. 122. – P. 2847-2856.
138. Min J.-Y. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2,,5,-oligo(A)synthetase [Text] / J.-Y. Min, R.M. Krug // Proc Natl Acad Sci USA. – 2006. – Vol. 103, № 18. – P. 7100-7105.
139. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV [Text] / T. Sheahan, T.E. Morrison,W. Funkhouser [et al.] // PLoS Pathog. – 2008. – Vol. 4, № 12. – P. e1000240.
140. Nelson, M.I. Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface [Text] / M.I. Nelson, A.L Vincent. // Trends Microbiol. – 2015. – 23 (3). – P. 142-53.
141. Neuraminidase and hemagglutinin matching patterns of a nighly pathogenic avian and two pandemic H1N1 influenza a viruses [Text] / Y. Zhang [et al.] // PLoS One. – 2010. – № 5(2). – P. 9167.
142. New horizon of mucosal immunity and vaccines [Text] / I. Takahashi, T. Nochi, Y. Yuri // Current opinion in immunologt. – 2009. –
Vol. 21. – P. 352-358.
143. New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases [Text] / M. Liang, D.C. Lye, M.I. Chen [et al.] // Singapore Med J. – 2009. –Vol. 50, № 6. – P. 581-583.
144. Novel pandemic influenza A (H1N1) virus infection modulates apoptotic pathways that impact its replication in A549 cells [Text] /
X. Wang [et al.] // Microbes Infect. – 2014. – Vol. 16 (3). – P. 178-186.
145. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A (H1N1) virus and severe clinical outcome, Norway 2009-2010 [Text] / A. Kilander [et al.] // Euro Surveill. – 2010. – Vol. 15, № 9.
146. Outbreak of swine-origin influenza A (H1N1) virus infection – Mexico, March–April 2009 [Text] / Centers for Disease Control and Prevention (CDC) // MMWR. – 2009. – Vol. 58, № 17. – Р. 467-470.
147. Pandemic H1N1 Influenza. Pathology and Pathogenesis of 100 Fatal Cases in the United States [Text] / W.J. Shieh [et al.] //
AJ. Pathol. – 2010 – Vol. 177. – P. 166-175.
148. Pandemic H1N1 Chronology, August 2009, (Электронный ресурс) – Режимдоступа: URL: http://www.wpro.who.int/NR/rdonlyres/ 18DB2FA5-5BE0-422B-B0FD-826 C5DD1 D7BD/0/PandemicH1N1_ Chronology_Aug09.pdf.
149. Pandemic (H1N1) 2009, Pan American Health Organization, 2009, (Электронный ресурс) – Режим доступа: URL: http://new.paho. org/hq/images/atlas/en/atlas.html.
150. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009–2010 / A. Bal, V. Suri, B. Mishra [et al.] // Histopathology. – 2012. – Vol. 60. – P. 326–335.
151. Pathogenesis of influenza-induced acute respiratory distress syndrome [Text] / K.R. Short, E.J. Kroeze, R.A. Fouchier [et al.] // Lancet Infect Dis. – 2014. – Vol. 14(1). – P. 57-69.
152. PB1-F2 influenza a virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments [Text] / C. Chevalier, A. Al Bazzal, J. Vidic [et al.] // J. Biol. Chem. – 2010. – Vol. 2815, № 2. – P. 13233-13243.
153. Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models [Text] / D. Kwon, K. Shin, S. Kim [et al.] // J. Microbiol. – 2010. – V. 48. – P. 657-662.
154. Peteranderl, C. Human influenza virus infections [Text] / C. Peteranderl, S. Herold, C. Schmoldt // Seminars in Respiratory and Critical Care Medicine. – 2016. – Vol. 37, № 4. – P. 487-500.
155. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection [Text] / Y.C.F. Su, J. Bahl, U. Joseph [et al.] // Nature Communications. – 2015. – Vol. 6. – P. 7952.
156. Pliyev, B.K. Extracellular NAD(+) inhibits human neutrophil apoptosis [Text] / B.K. Pliyev, A.V. Ivanova, V.G. Savchenko // Apoptosis. – 2014. –Vol. 19, № 4. – P. 581-593.
157. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico [Text] / R. Perez-Padilla, D. de la Rosa-Zamboni, S. Ponce de Leon [et al.] // N Engl J Med. – 2009.–Vol. 361, № 7. – P. 680-689.
158. Preparing for the second wave: lessons from current outbreaks, 28 august 2009, WHO Pandemic (H1N1) briefing note 09,(Электронныйресурс) – Режимдоступа:URL:http://www.who.int/csr/disease/swineflu/notes/h1n1_second_wave_20090828/en/index.html.
159. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [Text] / A.E. Fiore, D.K. Shay, K. Broder [et al.] // MMWR. – 2008. – Vol. 57, № RR-7. – Р. 1-60.
160. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells [Text] / A. Crawford, M. Macleod, T. Schumacher [et al.] // J Immunol. – 2006. – Vol. 176, № 6. – Р. 3498-3506.
161. Public Health Agency of Canada, weekly reports, 2008–2009 (week 34), (Электронный ресурс) – Режим доступа: URL: http://www.phac-aspc.gc.ca/fluwatch/08-09/w34_09/index-eng. php.
162. Public Health Agency of Canada, weekly reports, 2009–2010 (week48), (Электронныйресурс) – Режимдоступа: URL:http://www.phacaspc.gc.ca/fluwatch/09-10/w48_09/index-eng.php.
163. Raman, K. Flux balance analysis of biological systems: applications and challenges [Text] / K. Raman, N. Chandra // Briefings in Bioinformatics. – 2009. – Vol. 10, № 4. – P. 435-449.
164. Rello, J. Clinical review: primary influenza viral pneumonia [Text] / J. Rello, A. Pop-Vicas // Crit Care. – 2009. – № 13(6). – P. 235
165. Resperatory disease in adults during pandemic (H1N1) 2009 outbreak, Argentina [Text] / Zala C. [et al.] // Emerg. Infect. Dis. – 2009. – Vol. 15, № 12. – P. 2060-2061.
166. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine [Text] / Н.W. Kim, J.G. Canchola, C.D. Brandt [et al.] // Am. J. Epidemiol. – 2009. – Vol. 89, № 4. – P. 422-434.
167. Role for innate IFNs in determining respiratory syncytial virus immunopathology [Text] / T.R. Johnson, S.E. Mertz, N. Gitiban [et al.] // J. Immunol. – 2005. – Vol. 174, № 11. – P. 7234-7241.
168. Role of human Toll-like receptors in naturally occurring influenza infections / N. Lee, C.K. Wong, D.S. Hui [et al.] // Influenza other Respir. viruses. – 2013. – V. 7. – № 5. – P. 666-675.
169. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract [Text] / K.B. Renegar, P.A. Small, L.G. Boykins [et al.] // J. Immunol. – 2004. – Vol. 173, № 12. – P. 1978-1986.
170. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice [Text] / L. Qi [et al.] // J. Virol. – 2009. – Vol. 83, № 8. – P. 3754-3761.
171. Rozenbaum, M.H. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults: a meta-analysis [Text] / M.H. Rozenbaum, P. Pechlivanoglou, T.S. van der Werf // Eur. J. Clin. Microb. Infect. Dis. – 2013. – Р. 305-316.
172. Sant, A.J. Revealing the role of CD4(+) T cells in viral immunity [Text] / A.J. Sant, A. McMichael // J. Exp. Med. – 2012. – Vol. 209. – P. 1391-1395.
173. Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study [Text] / A. Bjarnason, G. Thorleifsdottir, A. Lоve [et al.] // PLoS One. – 2012. – Vol. 7(10). – Р. e46816.
174. Stanton, R.C. Glucose-6-Phosphate Dehydrogenase, NADPH, and Cell Survival [Text] / R.C. Stanton // IUBMB Life. – 2012. –
Vol. 64, № 5. – P. 362-369.
175. Structure of NADP(+)-dependent glutamate dehydrogenase from Escherichia coli-refl ections on the basis of coenzyme specifi city in the family of glutamate dehydrogenases [Text] / M. ASharkey, T. FOliveira, P.C. Engel [et al.] // FEBS J. – 2013. – № 280(18). – Р. 4681-4692.
176. Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity [Text] / J. Dаvila, G. Chowell, V.H. Borja-Aburto [et al.] // PLoS Curr. – 2014. – № 6. – P. 1-14.
177. Summary of situation of Pandemic (H1N1) 2009, (Электронный ресурс) – Режим доступа: URL: http://www. searo.who. int/EN/ Section 10/Section2562.htm.
178. Swine-origin influenza A (H1N1) virus infections in a school – New York City, April 2009 [Text] / Centers for Disease Control and Prevention // MMWR. – 2009. – Vol. 58, № 17. – Р. 470-472.
179. Synthesis and anti-influenza a virus activity of 6′-amino-6′-deoxy-glucoglycerolipids analogs [Text] / L. Ren, J. Zhang, H. Ma [et al.] // Marine Drugs. – 2016. – Vol. 14, № 6. – P. 116.
180. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese [Text] /
M.W. Ng, G. Zhou, W.P. Chong [et al.] // BMC Infect Dis. – 2007 – Vol. 7. – P. 50.
181. The fate of influenza A virus infection of human macrophages and dendritic cells / K.R. Short, A.G. Brooks, P.C. Reading [et al.] // J. General Virology. – 2012. – V. 93. – P. 2315-2325.
182. The Influenza virus resource at the National Center for Biotechnology Information [Text] / Y. Bao, P. Bolotov, D. Dernovoy [et al.] //
J. of Virology. – 2008. – Vol. 82, № 2. – P. 596-601.
183. The state of specific humoral immunity in the system «mother-newborn» in women who suffered influenza A(H3N2) in different trimesters of pregnancy [Text] / М.Т. Lutsenko, I.N. Gorikov, B.А. Rabinovich [et al.] // The 9th Sino-Russia Forum of Biomedical and Pharma-ceutical Forum. Harbin, China, 2012. – P. 280–281
184. Torres, A. Biomarkers and community-acquired pneumonia: tailoring management with biological data [Text] / A. Torres, P. Ramirez, B. Montull // Semin. Respir. Crit. Care Med. – 2012. – Vol. 33, № 3. – P. 266-271.
185. Torres, A. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review [Text] / A. Torres, F. Blasi, W.E. Peetermans // Eur. J. Clin. Microbiol. Infect. Dis. – 2014. – Vol. 33. – P. 1065-1079.
186. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969–2001 [Text] / C. Rizzo, A. Bella, C. Viboud [et al.] // Emerg. Infect. Dis. – 2007. – Vol. 13, № 5. – P. 694–699.
187. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells [Text] / G. Stary, C. Bangert, M. Tauber [et al.] // J Exp Med. – 2007. – Vol. 204, № 6. – P. 1441-1451.
188. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 [Text] / Centers for Disease Control and Prevention // MMWR (Morb Mortal Wkly Rep). – 2009. – Vol. 58, № 16. – Р. 433-435.
189. Van der Werf, S. Influenza – the need to stay ahead of the virus [Text] / S. Van der Werf, D. Levy-Bruhl // Eurosurveillance. – 2015. – Vol. 20, № 5. – P. 1-4.
190. Wang, Z. Avian influenza viruses, inflammation, and CD8+ T cell immunity [Text] / Z. Wang, L. Loh, L. Kedzierski // Frontiers in Immunology. – 2016. – Vol. 7. – P 60.
191. Weekly Epidemiological Monitor, November 2009, 2(44). (Электронныйресурс – Режимдоступа: http://www.emro. who.int/csr/h1n1/pdf/epi_monitor_44_09.pdf (дата обращения: 18.12.2009 г.).
192. WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness [Электронный ресурс] // Sept. 2015. – Режим доступа: http://www.who.int/influenza/vaccines/virus/201509_zoonotic_vaccinevirusupdate.pdf?ua=1.
193. WHO. 2009. Pandemic (H1N1) 2009–update 64. / World Health Organization. Situation Update, 8 January 2014. http://www.who.int/csr/don/2010_05_28/en/index.html.